Scale -


  • Revenue is 147 Rs Cr; Annual Growth is 34 %; Continuous Growth over 3 years; 5 Year CAGR is -13 %
  • Ebitda is 8.28 Rs Cr; Annual Growth is 69 %; Continuous Growth over 3 years; 5 Year CAGR is -40 %
  • PBT is 4.43 Rs Cr; Annual Growth is 272 %; 5 Year CAGR is -47 %
  • PAT is 2.08 Rs Cr; Annual Growth is 145 %; Continuous Growth over 3 years; 5 Year CAGR is -54 %

Profitability -


  • PBDIT Margin is 5.63 %; Annual Growth is 26 %; Continuous Growth over 3 years; in Bottom Quartile; 5 Year CAGR is -31 %
  • PAT Margin is 1.41 %; Annual Growth is 83 %; Continuous Growth over 3 years; in Bottom Quartile; 5 Year CAGR is -47 %
  • Quarterly Ebitda Margin is 8 %; in Bottom Quartile

Return -


  • ROCE is 3.43 %; Annual Growth is 166 %; Continuous Growth over 3 years; in Bottom Quartile; 5 Year CAGR is -42 %
  • ROA is 1.06 %; Annual Growth is 165 %; Continuous Growth over 3 years; in Bottom Quartile; 5 Year CAGR is -52 %
  • ROE is 1.15 %; Annual Growth is 167 %; Continuous Growth over 3 years; in Bottom Quartile; 5 Year CAGR is -52 %
  • Asset Turnover is 72 %; Annual Growth is 36 %; Continuous Growth over 3 years

Efficiency -


  • Operating cash flow is 3.3 Rs Cr; Annual Growth is 117 %; 5 Year CAGR is 24 %
  • Inventory Turnover Ratio is 3.36; Continuous Growth over 3 years
  • Current Ratio is 8.32; in Top Quartile; Annual Decline is -46 %; Continuous Decline over 3 years
  • Quick Ratio is 4.88; Annual Decline is -60 %; Continuous Decline over 3 years

Solvancy -


  • Debt/Equity is 0; Annual Decline is -100 %
  • Long term Debt is 0.22 Rs Cr; Annual Decline is -79 %
  • Total Debt is 0.72 Rs Cr; Annual Decline is -70 %; 5 Year CAGR is 73 %
  • Contingent Liabilities is 12.23 Rs Cr; Annual Growth is 203 %; Continuous Growth over 3 years; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 40 %; Annual Growth is 110 %; Continuous Growth over 3 years; 5 Year CAGR is 106 %
  • Operating cashflow/PAT is 159 %; Annual Growth is 107 %; 5 Year CAGR is 167 %
  • Change in Inventories/Total Expenses is -6 %; Continuous Decline over 3 years; in Bottom Quartile
  • Current Tax/PAT is 98 %; Annual Growth is 201 %; in Top Quartile; 5 Year CAGR is 30 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Nureca Ltd. Estimates – NSE:NURECA
Nureca Home Healthcare Products and Distribution Operations Explained
Nureca Limited (NURECA.NS) Rises 1.96% to ?319.4, Testing Key Resistance Band
Nureca Limited Reports Financial Results for Q2 and H1 FY27
Nureca posts highest quarterly revenue in five years, Q2 sales jump 55%
Nureca Q2 FY27 Results: Revenue at Rs 585 mn, PAT Rs 40 mn
Nureca Q2 Profit Rises to Rs 40.51 Million; Revenue Up 55%
Nureca Q2 Results: ??????? ?????? ??????! ??????????????? **55%** ???, ??????? ???? ????
Nureca Q2FY27 Results: Revenue up 55% YoY to ?58.53 crore, 20-quarter high
Nureca Upper Circuit Today: Price, Data and Peers
Nureca (NURECA.NS) Pulls Back -2.37% From ?328.91 Resistance 2026-10-20
Nureca Ltd closes DRI customs case with ?57.13 lakh appropriation
Nureca NSE:NURECA Q2 FY27 RTA Compliance Certificate Filed
Nureca Limited Q2 2026 Earnings: Revenue Climbs 34% YoY Even as Shares Slip 4.57%
Nureca NURECA Promoter Insider Trading Disclosure Oct 2026